Gossamer Bio, Inc. 10-K Cybersecurity GRC - 2024-03-05

Page last updated on July 16, 2024

Gossamer Bio, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-05 07:32:54 EST.

Filings

10-K filed on 2024-03-05

Gossamer Bio, Inc. filed a 10-K at 2024-03-05 07:32:54 EST
Accession Number: 0001728117-24-000019

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

Item 1C. Cybersecurity. Cybersecurity Risk Management and Strategy We have developed and implemented a cybersecurity program intended to protect the confidentiality, integrity, and availability of our critical systems and information. Our cybersecurity program includes a cybersecurity incident response plan. We design and assess our program based on the National Institute of Standards and Technology Cybersecurity Framework (NIST CSF). This does not imply that we meet any particular technical standards, specifications, or requirements, only that we use the NIST CSF as a guide to help us identify, assess, and manage cybersecurity risks relevant to our business. Our cybersecurity program is integrated into our overall risk management program and includes reporting channels to the executive management team and an internal Cybersecurity Oversight Committee, as well as governance processes which communicate cybersecurity risks to departments across the organization, including legal, strategic, operational, and financial areas. This encourages consideration of cybersecurity oversight, accountability and diligence across the organization. Our cybersecurity program includes: - Processes to assess cybersecurity risk, designed to help identify material cybersecurity risks to critical systems, information, products, services, and the broader enterprise information technology environment; - a security team principally responsible for coordinating and managing (1) cybersecurity risk evaluation processes, (2) implementation of cybersecurity controls, and (3) response to cybersecurity incidents; - the use of external service providers, where appropriate, to assess, test or otherwise assist with aspects of the organization’s cybersecurity controls; - cybersecurity awareness training of employees, incident response personnel, including third party providers, and senior management; - a cybersecurity incident response plan which includes procedures for responding to cybersecurity incidents; and - a third-party risk management process for service providers, suppliers, and vendors that have access to sensitive data or information. We have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents, which have materially affected or are reasonably likely to materially affect the organization, including operations, business strategy, results of operations, or financial condition. For more information, see the section titled “Risk Factors- Our information technology systems, or those of any of our CROs, manufacturers, other contractors or consultants or potential future collaborators, may fail or suffer security breaches, which could result in a material disruption of our seralutinib development program, which could materially affect our results.” Cybersecurity Governance Our Board considers cybersecurity risk as part of its risk oversight function and has delegated oversight of cybersecurity and other information technology risks to the Audit Committee. The Audit Committee oversees management’s implementation of the cybersecurity program. The Audit Committee receives formal annual reports from management regarding cybersecurity risks. In addition, management updates the Board and Audit Committee, as necessary, regarding any material cybersecurity incidents, as well as any incidents with lesser impact potential. The Audit Committee reports to the full Board regarding its activities, including those related to cybersecurity. Our management team including the Executive Vice President, Technical Operations and Administration is responsible for assessing and managing material risks from cybersecurity threats. The team has primary responsibility for our overall cybersecurity program and supervises both our internal cybersecurity personnel and our retained external cybersecurity consultants. Our management team’s experience includes collective decades of experience working in and overseeing information technology and cybersecurity functions, technical cybersecurity certifications, and active membership in cybersecurity professional organizations, as well as local groups, to support knowledge sharing and ongoing education. Our management team supervises efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources, including external consultants engaged by us and alerts and reports produced by security tools deployed in the information technology environment.


Company Information

NameGossamer Bio, Inc.
CIK0001728117
SIC DescriptionPharmaceutical Preparations
TickerGOSS - Nasdaq
Website
CategoryNon-accelerated filer
Smaller reporting company
Fiscal Year EndDecember 30